Tectonic Therapeutic: Competitor Data Strengthens The TX45 Bull Case
Tectonic Therapeutic's TX45 CpcPH-HFpEF program gains support from Merck's CADENCE data; Phase 1b hemodynamics and cash through Q1 2029 set…
Equity Eagle 2 clicksNASDAQ
Tectonic Therapeutic, Inc.
TECX
1 story
$404M Market cap · 2026-10-16
Equity Eagle 2 clicks